共 50 条
- [31] Phase II trial of becatecarin (rebeccamycin analogue) in relapsed sensitive small cell lung cancer (SCLC)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Dowlati, A.Mekhail, T.O'Brien, T.Rutherford, K.Snell, M.Ness, A.Ma, P.Ivy, S. P.Halmos, B.
- [32] Phase II trial of carfilzomib and irinotecan in relapsed small cell lung cancer (NCT01941316).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Arnold, Susanne M.Chansky, KariBaggstrom, Maria QuintosThompson, Michael A.Sanborn, Rachel E.Villano, JohnWaqar, Saiama NaheedHamm, John TurnerLeggas, MarkWillis, MauriceRosales, Joseph G.Crowley, John
- [33] Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC)JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Vigano, M. G.Cavina, R.Novello, S.Grossi, F.Santoro, A.Gregorc, V.Scagliotti, G.Garassino, I. M.Rossoni, G.Levra, M. G.Genova, C.Caligaris-Cappio, F.Lambiase, A.Bordignon, C.
- [34] Phase II trial of high-dose weekly topotecan in patients with relapsed small-cell lung cancer (SCLC)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Shipley, D.Spigel, D. R.Hainsworth, J. D.Whorf, R. C.Markus, T. M.Kuzur, M.Infante, J. R.Yardley, D. A.Burris, H. A., IIIGreco, F. A.
- [35] Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumorsNature Communications, 9Julie GeorgeVonn WalterMartin PeiferLudmil B. AlexandrovDanila SeidelFrauke LeendersLukas MaasChristian MüllerIlona DahmenTiffany M. DelhommeMaude ArdinNoemie LeblayGraham ByrnesRuping SunAurélien De ReyniesAnne McLeer-FlorinGraziella BoscoFlorian MalchersRoopika MenonJanine AltmüllerChristian BeckerPeter NürnbergViktor AchterUlrich LangPeter M. SchneiderMagdalena BogusMatthew G. SolowayMatthew D. WilkersonYupeng CunJames D. McKayDenis Moro-SibilotChristian G. BrambillaSylvie LantuejoulNicolas LemaitreAlex SoltermannWalter WederVerena TischlerOdd Terje BrustugunMarius Lund-IversenÅslaug HellandSteinar SolbergSascha AnsénGavin WrightBenjamin SolomonLuca RozUgo PastorinoIver PetersenJoachim H. ClementJörg SängerJürgen Wolf
- [36] Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumorsNATURE COMMUNICATIONS, 2018, 9George, JulieWalter, VonnPeifer, MartinAlexandrov, Ludmil B.Seidel, DanilaLeenders, FraukeMaas, LukasMueller, ChristianDahmen, IlonaDelhomme, Tiffany M.Ardin, MaudeLeblay, NoemieByrnes, GrahamSun, RupingDe Reynies, AurelienMcLeer-Florin, AnneBosco, GraziellaMalchers, FlorianMenon, RoopikaAltmuller, JanineBecker, ChristianNurnberg, PeterAchter, ViktorLang, UlrichSchneider, Peter M.Bogus, MagdalenaSoloway, Matthew G.Wilkerson, Matthew D.Cun, YupengMcKay, James D.Moro-Sibilot, DenisBrambilla, Christian G.Lantuejoul, SylvieLemaitre, NicolasSoltermann, AlexWeder, WalterTischler, VerenaBrustugun, Odd TerjeLund-Iversen, MariusHelland, AslaugSolberg, SteinarAnsen, SaschaWright, GavinSolomon, BenjaminRoz, LucaPastorino, UgoPetersen, IverClement, Joachim H.Saenger, JorgWolf, Jurgen
- [37] Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade GliomaJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5174 - +Hargrave, Darren R.Terashima, KeitaHara, JunichiKordes, Uwe R.Upadhyaya, Santhosh A.Sahm, FelixBouffet, EricPacker, Roger J.Witt, OlafSandalic, LarissaKieloch, AgnieszkaRusso, MarkCohen, Kenneth J.
- [38] Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trialNATURE COMMUNICATIONS, 2023, 14 (01)Lim, Sun MinPeters, SolangeGranados, Ana Laura OrtegaPinto, Gustavo dix JunqueiraFuentes, Christian SebastianLo Russo, GiuseppeSchenker, MichaelAhn, Jin SeokReck, MartinSzijgyarto, ZsoltHuseinovic, NedaZografos, EleftheriosBuss, ElenaStjepanovic, NedaODonnell, Seande Marinis, Filippo
- [39] A pilot study of adjuvant chemotherapy with cisplatin and irinotecan for high-grade pulmonary neuroendocrine carcinona (large cell neuroendocrine carcinoma and small cell lung cancer)JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Kenmotsu, H.Niho, S.Ito, T.Ishikawa, Y.Tada, H.Sekine, I.Watanabe, S.Yoshimura, M.Yamamoto, N.Oshita, F.Kubota, K.Nagai, K.
- [40] Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trialNature Communications, 14Sun Min LimSolange PetersAna Laura Ortega GranadosGustavo dix Junqueira PintoChristian Sebastián FuentesGiuseppe Lo RussoMichael SchenkerJin Seok AhnMartin ReckZsolt SzijgyartoNeda HuseinovicEleftherios ZografosElena BussNeda StjepanovicSean O’DonnellFilippo de Marinis